Peter Briggs

Adj ClinAssProf

ADJUNCT CLINICAL ASSOCIATE PROFESSOR, Medicine Monash Health

EmailPeter.Briggs@monash.edu

Research activity per year

If you made any changes in Pure these will be visible here soon.

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

10 Active

NSCLC: A Non-interventional Biomarker Study on the Molecular Evaluation of Archival Tumor Tissue in Subjects with Non-Small Cell Lung Cancer
Briggs, P.
5/05/20 → 4/05/25
Project: Research
A Phase 3 Multicenter, Randomized, Open Label, Active-controlled, Study of AMG 510 Versus Docetaxel for the Treatment of previously treated Locally Advanced and unresectable or Metastatic NSCLC Subjects With Mutated KRAS p.G12C
Briggs, P.
5/05/20 → 4/05/25
Project: Research
A Phase 3 Study of Pembrolizumab in Combination with Pemetrexed/Platinum (Carboplatin or Cisplatin) Followed by Pembrolizumab and Maintenance Olaparib vs Maintenance Pemetrexed in the First-Line Treatment of Participants with Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Briggs, P.
13/02/20 → 12/02/25
Project: Research
A Phase 3 Study of Pembrolizumab in Combination with Etoposide/Platinum (Cisplatin or Carboplatin) Followed by Pembrolizumab with or without Maintenance Olaparib in the First-line treatment of Participants with Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Briggs, P. & Parakh, S.
20/11/19 → 19/11/24
Project: Research
A Phase 3 Study of Pembrolizumab in Combination with Carboplatin/Taxane (Paclitaxel or Nab-paclitaxel) Followed by Pembrolizumab with or without Maintenance Olaparib in the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Briggs, P.
1/11/19 → 31/10/24
Project: Research

4 Article
2 Meeting Abstract

Systemic anticancer treatment changes at the start of the COVID-19 pandemic in a large metropolitan health service
Segelov, E., McLaren, C., Liow, E., Smith, S. T., Latham, S., Kong, J. B., Lam, M., Lum, C., Body, A. & Briggs, P., Nov 2020, In : Asia-Pacific Journal of Clinical Oncology. 16, S8, p. 91 1 p.
Research output: Contribution to journal › Meeting Abstract › Other › peer-review
Implementation of an immune-related adverse events (irAE) education program for healthcare professionals at an Australian multisite tertiary health service
Davies, A., Kwan, E. M., Briggs, P. & Segelov, E., 2019, In : Asia-Pacific Journal of Clinical Oncology. 15, S9, p. 191-192 2 p.
Research output: Contribution to journal › Meeting Abstract › Other › peer-review
Lung cancer interval times from point of referral to the acute health sector to the start of first treatment
Largey, G., Ristevski, E., Chambers, H., Davis, H. & Briggs, P., 25 Feb 2016, In : Australian Health Review. 40, 6, p. 649-654 6 p.
Research output: Contribution to journal › Article › Research › peer-review

7 Citations (Scopus)
Audit of referral pathways in the diagnosis of lung cancer: a pilot study
Largey, G., Chakraborty, S. P., Tobias, T., Briggs, P. & Mazza, D., 2015, In : Australian Journal of Primary Health. 21, 1, p. 106 - 110 5 p.
Research output: Contribution to journal › Article › Research › peer-review

8 Citations (Scopus)
Dynamic four-dimensional computed tomography for preoperative assessment of lung cancer invasion into adjacent structures
Choong, C. K. C., Pasricha, S. S., Li, X., Briggs, P., Ramdave, S., Crossett, M. & Troupis, J. M., Feb 2015, In : European Journal of Cardio-Thoracic Surgery. 47, 2, p. 239-243 5 p., ezu265.
Research output: Contribution to journal › Article › Research › peer-review

13 Citations (Scopus)